"Medical Research International is a full service clinical research site that delivers high quality clinical research services through a highly trained, experienced and dedicated staff. MRI has worked with many major pharmaceutical companies and CRO’s and is committed to providing accurate study results with reliable clinical data, in addition to providing high quality care to patients."

During the past decade, Medical Research International conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Research International" #1 sponsor was "Ipsen" with 1 trials, followed by "Member Companies of the Opioid PMR Consortium" with 1 trials sponsored, "Revance Therapeutics, Inc." with 1 trials sponsored, "Seikagaku Corporation" with 1 trials sponsored and "Yiling Pharmaceutical Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Medical Research International" are "Drug Abuse" (1 trials), "Hallux Abducto Valgus" (1 trials), "Influenza, Human" (1 trials), "Lumbar Disc Herniation" (1 trials) and "Narcotic Abuse" (1 trials). Many other conditions were trialed in "Medical Research International" in a lesser frequency.

Most popular intervention types in "Medical Research International" are "Drug" (4 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Botulinum toxin type A" (1 trials), "Continuation of opioid therapy (morphine sulfate ER, oxycodone ER, oxymorphone ER)" (1 trials), "DAXI for Injection: HIGH Dose" (1 trials) and "DAXI for Injection: LOW Dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical Research International" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Medical Research International". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Medical Research International, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Research International, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".